# loestrin1-20.com

- **Website:** <https://loestrin1-20.com>
- **Primary alias:** `loestrin1-20.com`

## Description

Lo Loestrin® Fe, developed by AbbVie, is a leading low-dose birth control pill that offers effective pregnancy prevention with just 10 micrograms of estrogen. Being the only birth control option with this minimal estrogen dosage, it provides a safer alternative for women seeking to manage their reproductive health. Over four million women have chosen Lo Loestrin® Fe, making it the #1 prescribed branded birth control pill by OB/GYNs. 

In addition to its core function of preventing pregnancy, Lo Loestrin® Fe aims to reduce potential side effects associated with higher estrogen levels. AbbVie also offers a co-pay savings program for eligible patients, allowing prescriptions to cost as little as $30 for a one-month supply or $70 for three months, making it more accessible for users. Safety information and guidelines are prioritized, as the product includes important risk warnings and side effects. Lo Loestrin® Fe empowers women by providing a trusted solution for their birth control needs.

## Industries

- ⛑ Health
- ⛑ Womens Health _(under Health)_
- ⛑ Biotechnology and Pharmaceuticals _(under Health)_

## Links

- [facebook](https://facebook.com/LoLoestrinFe)
- [instagram](https://instagram.com/loloestrinferx)

## Logos & icons

- logo _(primary)_ — PNG — [download](https://cdn.brandfetch.io/idHPldxZRO/w/439/h/69/theme/dark/logo.png?c=1bxid64Mup7aczewSAYMX&t=1723177996808)
- icon _(primary)_ — JPEG — [download](https://cdn.brandfetch.io/idHPldxZRO/w/2048/h/2048/theme/dark/icon.jpeg?c=1bxid64Mup7aczewSAYMX&t=1723177997480)

## Colors

| Name | Hex | Theme |
| --- | --- | --- |
| Affair | #7b4299 | accent |
| Emperor | #545252 | dark |
| Carnation | #fa5358 | light |

## Fonts

- Bebas — asset _(custom)_
- Proxima Nova Regular — asset _(custom)_

---

_Source: <https://brandfetch.com/loestrin1-20.com>_
_See [/llms.txt](/llms.txt) for a full list of agent-readable pages, and [/auth.md](/auth.md) for how agents authenticate._